By proceeding, you agree to our Terms of Use and Privacy Policy.
Bispecific antibodies are generating increased excitement for their potential to effectively target complex diseases through a dual-engagement approach. There are many new and powerful breakthroughs with bispecific antibodies relating to fine tuning of bispecific antibodies, combinational therapies, and microenvironment modulation. Despite improvements, some persistent issues with bispecific antibodies are cytokine release syndrome, short half-lives, and regulating biodistribution. Join us for the 6th Annual Bispecific Antibodies for Cancer Immunotherapy conference to celebrate recent innovations and explore solutions to some of the most challenging problems in the bispecific antibody space.
Discover the future of bispecific antibody immunotherapy and connect with leaders.
Take a deep dive and deepen your understanding of bispecific antibody immunotherapy through informative sessions, expert panels, and scientific discussions.
Connect with key opinion leaders, industry pioneers, and fellow attendees, fostering meaningful collaborations and expanding your professional network.
Be inspired by visionary talks, success stories, and case studies, igniting your passion for transforming cancer treatment and improving patient outcomes.
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.
Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost. FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILM’s global center for new drug development.
Sanyou Biopharmaceuticals Co., Ltd. is a leading international biological high-tech enterprise focusing on R&D and services of innovative antibody drugs.
The CDMO segment of the world's leading biotech company GenScript.
Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges.
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.
Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal immunization, single B cell screening, to antibod
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for
NeoSome Life Sciences is a PreClinical Research Organization providing in life modeling for several therapeutic research areas. We offer a range of services from Proof of Concept to IND enabling studies. Our specialties include Infectious Diseases, O
NeoSome Life Sciences is a PreClinical Research Organization providing in life modeling for several therapeutic research areas. We offer a range of services from Proof of Concept to IND enabling studies. Our specialties include Infectious Diseases, Oncology, Toxicology, and General Pharmacology.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.